Published date: 9 April 2021

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 1 April 2021, 12pm

Contract summary

Industry

  • Medical equipments, pharmaceuticals and personal care products - 33000000

  • Blood-testing reagents - 33696200

Location of contract

Any region

Value of contract

£26,094

Procurement reference

tender_126845/948788

Published date

9 April 2021

Closing date

1 April 2021

Closing time

12pm

Contract start date

2 April 2021

Contract end date

31 March 2022

Contract type

Supply contract

Procedure type

Call-off from a framework agreement

A mini-competition or direct purchase from a pre-established framework agreement.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

The Government must protect the health and well-being of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 Jan 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 Mar 2020.
PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004).
Public Health England (PHE) has awarded a contract for the purchase of Spike RBD Antibody, Antigen Affinity Purified to Stratech Scientific Ltd, via direct award under PHE Microbiology Framework - Lot 2.

More information

Attachments

Award information

Awarded date

1 April 2021

Contract start date

2 April 2021

Contract end date

31 March 2022

Total value of contract

£26,094

This contract was awarded to 1 supplier.

Stratech Scientific Ltd

Address

Cambridge House, St. Thomas Place, Ely, England, CB7 4EX

Reference

Companies House number: 01690218

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Address

61 Colindale Avenue
London
NW9 5EQ
England

Email

Mihaela.Tinca@phe.gov.uk